Related Experiment Video
Updated: Sep 14, 2025

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
Gastroprotective effect of polysaccharides from Agaricus blazei Murill against ethanol-induced gastric ulcer in mice
João Francisco Câmara Neto1, Matheus da Silva Campelo1, Mac Dionys Rodrigues da Costa2
1Department of Organic and Inorganic Chemistry, Science Center, Federal University of Ceará, Fortaleza, CE, ZIP code 60440-900, Brazil.
Abstract:
This study aims to isolate and characterize the physicochemical properties and evaluate the cytoprotective and gastroprotective potential of polysaccharides from the Agaricus blazei Murill mushroom (PAbM). The PAbM were isolated and characterized chemically. The cytoprotective potential of PAbM was studied using LLC-MK2 cells through the acetic acid-induced cell injury model. The gastroprotective activity was studied using the ethanol-induced gastric ulcer model. The PAbM showed a molecular mass of 4.7 × 105 g mol-1 and polydisperse character, being composed by glucose, mannose and galactose monomers. In vitro study showed the low cytotoxicity of PAbM against LLC-MK2 cells and their ability to attenuate cellular injury (3.12 and 6.25 μmol/L) caused by exposure to acetic acid, being able to reduce the parameters related to oxidative stress and prevent the occurrence of cellular alterations. The in vivo assay demonstrated the ability of PAbM (50 and 150 mg/kg, p.o.) to alleviate the morphological changes in the gastric mucosa induced by the administration of ethanol. PAbM were able to reduce tissue mastocytosis and these results were more promising than those obtained for reference drug (carbenoxolone at 200 mg/kg, p.o.). The administration of PAbM was able to reduce TBARS levels and increase GSH levels, evidencing their in vivo antioxidant activity. Thus, this study reports the gastroprotective potential of PAbM and encourages future studies in the preclinical context to better understand the mechanisms linked to this activity and their use in clinical trials aimed at a new treatment for gastric ulcer.
More Related Videos
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

